Hester Biosciences Sells Texas Lifesciences 11% Stake

Transaction Summary

Hester Biosciences Limited has divested its entire remaining equity stake in Texas Lifesciences Private Limited (TLPL). The company transferred 543,248 equity shares, representing 11% of TLPL's paid-up equity share capital, to existing shareholders of TLPL.

Transaction Details

• Transaction Date: July 8, 2026
• Number of Shares Sold: 543,248 equity shares
• Percentage Stake Sold: 11% of TLPL's paid-up equity share capital
• Consideration Amount: ₹23 million (aggregate)
• Counterparties: Existing shareholders of Texas Lifesciences Private Limited

Shareholding Impact

Following this transaction, Hester Biosciences' shareholding in Texas Lifesciences Private Limited has been reduced from 11% to zero. The company no longer holds any equity investment in TLPL.

Authorization

The transaction was executed in accordance with terms previously approved by the Board of Directors of Hester Biosciences Limited.